| 名稱 | MSH2 c.943-1G>T Reference Standard |
| 型號(hào) | CBP10591 |
| 報(bào)價(jià) | 900 |
| 特點(diǎn) | MSH2 c.943-1G>T Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 治療疼痛的潛力靶點(diǎn)——NGF
- 細(xì)胞株開(kāi)發(fā)的主要過(guò)程要知道
- BCMA靶點(diǎn)藥物細(xì)胞篩選模型
- 【連載-企業(yè)參考品】 急性淋巴細(xì)胞白血病的診斷參考品的選擇
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù)：誰(shuí)來(lái)給韓春雨事件畫(huà)上句號(hào)？
- ATCC細(xì)胞單純的固定液一般難以達(dá)到這些要求
- ATCC細(xì)胞株開(kāi)發(fā)的四階段簡(jiǎn)介
- PD-1/L1 &4-1BB雙靶點(diǎn)細(xì)胞篩選模型
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10591MSH2 c.943-1G>T Reference Standard
- 詳細(xì)內(nèi)容
CBP10591 | |
| Format | Genomic DNA |
| Description | MSH2, mutS homolog 2, is a tumor suppressor that functions as part of the DNA mismatch repair system and is associated with microsatellite instability (MSI) and genomic stability. Mutations in MSH2 are associated with susceptibility to colon cancer and endometrial cancer, and germline MSH2 mutations are associated with Lynch (Hereditary Nonpolyposis Colorectal Cancer) syndrome (HNPCC1). |
| Technical Data | |
| DNA Change | c.943-1G>T |
| AA Change | N/A |
| Mutation type | Splice_Site |
| Zygosity | N/A |
| Allelic Frequency | N/A |
| Transcript | NM_000251.3 |
| Cosmic ID | N/A |
| Chr position(GRCh37) | chr2-47643434-G-T |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)